737 HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE RATES AND ASSOCIATED FACTORS IN CHRONIC HEPATITIS B INFECTION
β Scribed by S. Yapali; B. Bayrakci; M. Akyildiz; R. Vardar; F. Gunsar; G. Ersoz; Z. Karasu; T. Ilter; U.S. Akarca
- Book ID
- 117378821
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 128 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Antibody to hepatitis B surface antigen (HBsAg) (antiβHBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and antiβHBs (concurrent HBsAg/ antiβHBs) with hepatocellular carcinoma (HCC). The aim of t
We fully agree with Dr. Yu and co-workers that maintaining the initial doses of ribavirin during the treatment play a decisive role in attaining sustained virological response (SVR). According to Davis et al., 2 the impact of dose reduction on SVR rates appeared to be greatest in patients who had to
A commercial radioimmunoassay was adapted to detect serum Dane particle-associated HBeAg in patients whose sera contained the homologous antibody. HBeAg was released from Dane particles with guanidine HC1. Dane particles were separated from anti-HBe by gel-filtration (Sepharose 4B) and ultracentrif